Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other Non-Current Assets (2016 - 2026)

Rockwell Medical filings provide 16 years of Other Non-Current Assets readings, the most recent being $556000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 5.3% to $556000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $556000.0, a 5.3% increase, with the full-year FY2025 number at $556000.0, up 5.3% from a year prior.
  • Other Non-Current Assets hit $556000.0 in Q4 2025 for Rockwell Medical, down from $561000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $729000.0 in Q3 2021 to a low of $509000.0 in Q2 2022.
  • Median Other Non-Current Assets over the past 5 years was $538000.0 (2024), compared with a mean of $561500.0.
  • Biggest five-year swings in Other Non-Current Assets: increased 15.9% in 2021 and later dropped 28.4% in 2022.
  • Rockwell Medical's Other Non-Current Assets stood at $619000.0 in 2021, then fell by 15.51% to $523000.0 in 2022, then increased by 0.76% to $527000.0 in 2023, then grew by 0.19% to $528000.0 in 2024, then grew by 5.3% to $556000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $556000.0 (Q4 2025), $561000.0 (Q3 2025), and $561000.0 (Q2 2025) per Business Quant data.